ConductScience.org, home

Paper28678784

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.

Sahin U and 49 others. Nature, 2017. Cited by 1,955 papers, by iCite.

Cite this record

ConductScience Library. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Papers, record 28678784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28678784

Download JSON
Disease
melanoma589 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
PubMed
Journal
Nature
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1,955
iCite
Relative citation ratio, by iCite
58.5
iCite
Revised in PubMed
2021-01-03
PubMed

Authors50

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sahin UUgur
2Derhovanessian EEvelyna
3Miller MMatthias
4Kloke BPBjörn-Philipp
5Simon PPetra
6Löwer MMartin
7Bukur VValesca
8Tadmor ADArbel D
9Luxemburger UUlrich
10Schrörs BBarbara
11Omokoko TTana
12Vormehr MMathias
13Albrecht CChristian
14Paruzynski AAnna
15Kuhn ANAndreas N
16Buck JJanina
17Heesch SSandra
18Schreeb KHKatharina H
19Müller FFelicitas
20Ortseifer IInga

Source PubMed

See all 50 authorsDownload CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cancer VaccinesMajor topic
MelanomaMajor topic
MutationMajor topic
Precision MedicineMajor topic
RNAMajor topic
Antibodies, Monoclonal
B7-H1 Antigen
CD8 Antigens
Epitopes
Humans
Immunotherapy
Neoplasm Metastasis
Neoplasm Recurrence, Local
Nivolumab
Programmed Cell Death 1 Receptor
T-Lymphocytes
Vaccination
beta 2-Microglobulin

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04072900A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in MelanomaResultsClinicalTrials.gov
NCT07686744Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell CarcinomaBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections5

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in28678783Cancer: Precision T-cell therapy targets tumours.https://conductscience.org/library/papers/28678783PubMed
Comment in28740114Tumour vaccines: Personal training by vaccination.https://conductscience.org/library/papers/28740114PubMed
Comment in28813655Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.https://conductscience.org/library/papers/28813655PubMed
Comment in28867556Neoantigen Vaccines Pass the Immunogenicity Test.https://conductscience.org/library/papers/28867556PubMed
Comment in31538056To each his own: a personalized vaccine for metastatic melanoma.https://conductscience.org/library/papers/31538056PubMed

Download CSV of comments and corrections

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126205340Evolving synergistic combinations of targeted immunotherapies to combat cancer.Nat Rev Cancer2015https://conductscience.org/library/papers/26205340PubMed
222373417Optimizing de novo transcriptome assembly from short-read RNA-Seq data: a comparative study.BMC Bioinformatics2011https://conductscience.org/library/papers/22373417PubMed
316940422Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.Blood2006https://conductscience.org/library/papers/16940422PubMed
425901682Mutant MHC class II epitopes drive therapeutic immune responses to cancer.Nature2015https://conductscience.org/library/papers/25901682PubMed
511932250BLAT--the BLAST-like alignment tool.Genome Res2002https://conductscience.org/library/papers/11932250PubMed
627959684T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.N Engl J Med2016https://conductscience.org/library/papers/27959684PubMed
725428505PD-1 blockade induces responses by inhibiting adaptive immune resistance.Nature2014https://conductscience.org/library/papers/25428505PubMed
825765070Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.Science2015https://conductscience.org/library/papers/25765070PubMed
917063328Magnetic particles for the separation and purification of nucleic acids.Appl Microbiol Biotechnol2006https://conductscience.org/library/papers/17063328PubMed
1017379693Enhancements and modifications of primer design program Primer3.Bioinformatics2007https://conductscience.org/library/papers/17379693PubMed
1118516045Mapping and quantifying mammalian transcriptomes by RNA-Seq.Nat Methods2008https://conductscience.org/library/papers/18516045PubMed
1220410931Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo.Gene Ther2010https://conductscience.org/library/papers/20410931PubMed
1327869121Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry.Nat Commun2016https://conductscience.org/library/papers/27869121PubMed
1419934295Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.Clin Cancer Res2009https://conductscience.org/library/papers/19934295PubMed
1525837513Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.Science2015https://conductscience.org/library/papers/25837513PubMed
1622517427Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration.Brief Bioinform2013https://conductscience.org/library/papers/22517427PubMed
1721045153Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.Cancer Res2010https://conductscience.org/library/papers/21045153PubMed
1828228285Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction.Immunity2017https://conductscience.org/library/papers/28228285PubMed
1923296927Synthetic mRNAs with superior translation and stability properties.Methods Mol Biol2013https://conductscience.org/library/papers/23296927PubMed
2018503082IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis.Nucleic Acids Res2008https://conductscience.org/library/papers/18503082PubMed

See all 42 referencesDownload CSV of references

Cited by1,510

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,955 citations.

PMIDTitleJournalYearIn PapersSource
42936394Tumor antigens across cancer progression: from immune recognition and selection to precision cancer immunotherapy.Front Immunol2026https://conductscience.org/library/papers/42936394PubMed
42928874Nanotechnology-Enabled Immunotherapy for Colorectal Cancer: Overcoming the "Cold" Tumor Microenvironment in Microsatellite-Stable Disease.Int J Nanomedicine2026https://conductscience.org/library/papers/42928874PubMed
42926996Functional Immunopeptidomics by Characterizing Immunopeptides Against HLAs, TCRs, and Antibodies.Res Sq2026https://conductscience.org/library/papers/42926996PubMed
42920849Progress on therapeutic mRNA vaccines for cancer.Front Oncol2026https://conductscience.org/library/papers/42920849PubMed
42909179Mapping programmable mRNA research relevant to cancer-associated immune escape: a dual-database bibliometric and topic modeling analysis.Front Oncol2026https://conductscience.org/library/papers/42909179PubMed
42886329Cancer nanomedicine and RNA/Lipid nanoparticle platforms in oncology: developmental evolution, translational barriers, and precision-therapy opportunities.J Egypt Natl Canc Inst2026https://conductscience.org/library/papers/42886329PubMed
42886326The haunted Umwelt: a biosemiotic and hauntological account of immune semiotic corruption in field cancerization.Theory Biosci2026https://conductscience.org/library/papers/42886326PubMed
42871894A bottleneck-first evaluation of antigen delivery platforms for therapeutic cancer vaccines.Mater Today Bio2026https://conductscience.org/library/papers/42871894PubMed
42866351Exploring the potential of mRNA vaccines in combatting communicable and non-communicable diseases in low-income and lower-middle-income countries.Ann Med Surg (Lond)2026https://conductscience.org/library/papers/42866351PubMed
42854694AI-integrated RNA therapeutics in precision oncology.Cell Rep Med2026https://conductscience.org/library/papers/42854694PubMed
42844249Bioengineering strategies for improving the immunogenicity of mRNA vaccines.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42844249PubMed
42835554Personalized messenger RNA therapy for melanoma and the challenge of global implementation.JAAD Int2026https://conductscience.org/library/papers/42835554PubMed
42827008Self-Assembling Peptide-Adjuvant Conjugate (SaPAC) Platform for Precision Cancer Immunotherapy.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42827008PubMed
42820749Epitope Generation Gateway: A biological context-dependent approach to cancer vaccine development.Gigascience2026https://conductscience.org/library/papers/42820749PubMed
42798884Personalised neoantigen vaccines for precision oncology in Southeast Asia: clinical opportunities, infrastructure challenges, and policy perspectives.Front Immunol2026https://conductscience.org/library/papers/42798884PubMed
42798731AI-driven genotype-phenotype modeling: a framework integrating multi-modal single-cell genomics and reverse vaccinology for de novo design of multi-epitope cancer vaccines.Front Genet2026https://conductscience.org/library/papers/42798731PubMed
42797572From Universal Aspiration to Precision Immunization: A Hypothesis Framework for Antigen-Defined, HLA-Restricted Cancer Vaccines.Vaccines (Basel)2026https://conductscience.org/library/papers/42797572PubMed
42787418Molecular subgroups and biomarker guided precision immunotherapy in triple-negative breast cancer: advances, challenges, and future directions.Front Immunol2026https://conductscience.org/library/papers/42787418PubMed
42786286Localized immunotherapy via dissolving microneedles for the prevention of breast cancer recurrence.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42786286PubMed
42783445COVID-19 mRNA Vaccines as Antigen-Agnostic Immunomodulators: A Repurposing Perspective.Med Sci (Basel)2026https://conductscience.org/library/papers/42783445PubMed

See all 1,510 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
HLA-G3135PubTator's text mininghttps://conductscience.org/library/genes/3135NCBI Gene
SPATA29825PubTator's text mininghttps://conductscience.org/library/genes/9825NCBI Gene

Download CSV of genes

Drugs3

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
IMIQUIMODCHEMBL1282Results1https://conductscience.org/library/drugs/CHEMBL1282ChEMBL
REGRAMOSTIMCHEMBL2107881Results1https://conductscience.org/library/drugs/CHEMBL2107881ChEMBL
TORIPALIMABCHEMBL4297843Results1https://conductscience.org/library/drugs/CHEMBL4297843ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28678784

GET https://conductscience.org/api/papers/v1/28678784/authors?page=2